<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">Therefore, repurpose of existing antiviral agents including interferon, chloroquine (an anti-malarial agent) and niclosamide (a broad spectrum anthelminthic) have attracted considerable attention and many trials are underway 
 <xref rid="b0020" ref-type="bibr">[4]</xref>, 
 <xref rid="b0025" ref-type="bibr">[5]</xref>. The current paper reviews the evidence to explore the potential of diethyl carbamazine (DEC) to be used successfully as a therapeutic agent for the disease.
</p>
